Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05382299
Other study ID # GS-US-592-6238
Secondary ID 2021-005743-79DO
Status Recruiting
Phase Phase 3
First received
Last updated
Start date July 20, 2022
Est. completion date May 2027

Study information

Verified date June 2024
Source Gilead Sciences
Contact Gilead Clinical Study Information Center
Phone 1-833-445-3230 (GILEAD-0)
Email GileadClinicalTrials@gilead.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary objective of this study is to compare the progression-free survival (PFS) between sacituzumab govitecan-hziy (SG) versus treatment of physician's choice (TPC) in participants with previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors do not express programmed cell death ligand 1 (PD-L1) or in participants previously treated with anti-programmed cell death (ligand or protein) 1 (Anti-PD-(L)1) Agents in the early setting whose tumors do express PD-L1.


Recruitment information / eligibility

Status Recruiting
Enrollment 540
Est. completion date May 2027
Est. primary completion date May 2027
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Key Inclusion Criteria: - Individuals, regardless of race and ethnic group, with previously untreated locally advanced, inoperable or metastatic triple-negative breast cancer (TNBC) - Individuals whose tumors are programmed cell death ligand 1 (PD-L1) negative at screening or individuals whose tumors are PD-L1 positive at screening if they have received an anti-PD-(L)1 inhibitor in the (neo) adjuvant setting or if they cannot be treated with a checkpoint inhibitor due to a comorbidity - Centrally confirmed TNBC and PD-L1 status on fresh or archival tissue - Individuals must have completed treatment for Stage I-III breast cancer, if indicated, and = 6 months must have elapsed (with the exception of endocrine therapy) between completion of treatment with curative intent and first documented local or distant disease recurrence - Individuals presenting with de novo metastatic TNBC are eligible - Measurable disease based on computed tomography (CT) or magnetic resonance imaging (MRI) in accordance with per Response Evaluation Criteria in Solid Tumors (RECIST) Version 1.1. as evaluated locally - Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 - Demonstrates adequate organ function - Male individuals and female individuals of childbearing potential who engage in heterosexual intercourse must agree to use protocol-specified method(s) of contraception - Individuals with human immunodeficiency virus (HIV) must be on antiretroviral therapy (ART) and have a well-controlled HIV infection/disease Key Exclusion Criteria: - Positive serum pregnancy test or women who are lactating - Received systemic anticancer treatment within the previous 6 months or radiation therapy within 2 weeks prior to enrollment - Have not recovered from adverse events (AEs) due to a previously administered agent at the time study entry - May not be participating in a study with an investigational agent or investigational device within 4 weeks prior to randomization. Individuals participating in observational studies are eligible - Previously received topoisomerase 1 inhibitors or antibody drug conjugates containing a topoisomerase inhibitor - Active second malignancy - Active serious infection requiring antibiotics - Positive for HIV-1 or 2 with a history of Kaposi sarcoma and/or Multicentric Castleman Disease - Active hepatitis B virus (HBV) or hepatitis C virus (HCV) infection Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Study Design


Intervention

Drug:
Sacituzumab Govitecan-hziy
Administered intravenously
Paclitaxel
Administered intravenously
nab-Paclitaxel
Administered intravenously
Gemcitabine
Administered intravenously
Carboplatin
Administered intravenously

Locations

Country Name City State
Argentina Hospital Británico de Buenos Aires Buenos Aires
Argentina Instituto de Oncologia Angel H.Roffo Caba
Argentina Fundacion CORI para la Investigacion y Prevencion del Cancer Capital
Argentina Instituto de Oncología de Rosario Rosario
Argentina Centro para la Atencion Integral del Paciente Oncologico Centro Médico C.A.I.P.O San Miguel de Tucumán
Argentina Clinica Viedma Viedma
Australia Cancer Research SA (CRSA) Adelaide South Australia
Australia Border Medical Oncology Albury New South Wales
Australia Monash Medical Centre Clayton Victoria
Australia Icon Cancer Centre Hobart Hobart Tasmania
Australia Saint George Hospital - Australia Kogarah New South Wales
Australia Austin Hospital Melbourne Victoria
Australia Breast Cancer Research Center - Western Australia Nedlands Western Australia
Australia Mater Hospital - North Sydney North Sydney New South Wales
Australia Mater Misericordiae Limited and Mater Research Limited South Brisbane Queensland
Australia GenesisCare - North Shore St Leonards New South Wales
Australia Princess Alexandra Hospital Woolloongabba Queensland
Austria Universitätsklinikum Graz Graz
Austria Medizinische Universität Innsbruck Innsbruck
Austria Ordensklinikum Linz GmbH Barmherzige Schwestern Linz
Austria Landeskrankenhaus Salzburg Salzburg
Austria Universitätsklinikum Sankt Pölten Sankt Poelten
Austria Medizinische Universität Wien Wien
Austria Landesklinikum Wiener Neustadt Wiener Neustadt
Belgium Algemeen Ziekenhuis Klina Brasschaat
Belgium Cliniques Universitaires Saint-Luc Brussels
Belgium Universitair Ziekenhuis Brussel Brussels
Belgium Grand Hopital de Charleroi - Notre Dame Charleroi
Belgium Universitair Ziekenhuis Gent Gent
Belgium UZ Leuven Leuven
Belgium Centre Hospitalier Universitaire Université Cathol Namur
Brazil Hospital Araújo Jorge - Associação de Combate ao Câncer em Goiás - ACCG Goiânia
Brazil ONCOSITE - Centro de Pesquisa Clinica em Oncologia Ijui
Brazil Catarina Pesquisa Clínica Itajai
Brazil Hospital Amaral Carvalho Jau
Brazil Hospital de Clinicas de Porto Alegre - HCPA Porto Alegre
Brazil Hospital Moinhos de Vento Porto Alegre
Brazil Hospital Sao Lucas da PUCRS Porto Alegre
Brazil Instituto Nacional de Câncer - INCA - HCIII Rio de Janeiro
Brazil Núcleo de Oncologia da Bahia Salvador
Brazil CEPHO - Centro de Estudos e PesquisaS de Hematologia e Oncologia Santo Andre
Brazil Clinica de Pesquisas e Centro de Estudos em Oncolo São Paulo
Brazil Fundação Pio XII - Hospital de Amor de Barretos São Paulo
Brazil Nucleo de Pesquisa Clinica da Rede Sao Camilo São Paulo
Brazil Real e Portuguesa de Beneficéncia - Hospital Beneficéncia Portuguesa (BP) - Unidade Paulista São Paulo
Canada Cross Cancer Institute Edmonton
Canada QEII Health Sciences Centre Halifax
Canada Grand River Regional Cancer Centre at Grand River Hospital Kitchener
Canada London Health Sciences Centre London
Canada McGill University Health Centre Montreal
Canada Jewish General Hospital Montréal
Canada Ottawa Hospital - General Campus Ottawa
Canada CISSS du Bas-Saint-Laurent - Hôpital régional de Rimouski Rimouski
Canada Mount Sinai Hospital Toronto
Canada Sunnybrook Research Institute Toronto
Canada British Columbia Cancer - Vancouver Vancouver
Chile Oncovida - Santiago Providencia
Chile Clínica Alemana Santiago
Chile Clínica IRAM Santiago DE CHILE
Chile Centro de Oncología de Precisión Santiago Region
Chile James Lind Centro de Investigacion del Cancer Temuco
China Beijing Cancer Hospital Beijing
China Cancer Hospital Chinese Academy of Medical Sciences Beijing
China Peking University People's Hospital Beijing
China The First Medical Center of Chinese PLA General Hospital Beijing
China Sichuan Cancer Hospital Chengdu
China West China Hospital, Sichuan University Chengdu
China Chongqing University Cancer Hospital Chongqing
China Deyang People's Hospital Deyang
China Sun Yat-Sen University Cancer Center Guangzhou
China Sir Run Run Shaw Hospital, Zhejiang University School of Medicine Hangzhou
China Harbin Medical University Cancer Hospital Harbin
China Anhui Provincial Cancer Hospital Hefei
China The Second Hospital of Anhui Medical University Hefei
China The Second Hospital of Jilin University Jilin Sheng
China Shandong Cancer Hospital Jinan
China Nanchang People's hospital Nanchang
China Hubei Cancer Hospital Wuhan
China Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan
China The First Affiliated Hospital of Xi'an Jiaotong University Xi'an
China The First Affiliated Hospital of Wenzhou Medical University Zhejiang
China The Second Affiliated Hospital of Zhejiang University School of Medicine Zhejiang
Czechia Masarykuv onkologicky ustav, klinika komplexni onkologickie pece Brno
Czechia Fakultní Thomayerova nemocnice Hradec Kralove
Czechia Fakultni nemocnice Hradec Kravlove, Klinika onkologie a radioterapie Hradec Králové
Czechia Fakultni nemocnice Olomouc, Onkologicka klinika Olomouc
Czechia Vseobecna Fakultni Nemocnice v Praze Prague
Czechia Fakultni nemocnice Karlovske Vinohrady, Radioterapeuticka a onkologicka klinika Praha
France Sainte Catherine Institut du Cancer Avignon Provence Avignon
France Centre Hospitalier Régional et Universitaire de Be Besancon
France Hôpital Morvan, Institut de cancérologie Brest
France Centre francois Baclesse Caen
France Centre Jean Perrin Clermont Ferrand
France Centre de Cancérologie du Grand Montpellier Montpellier
France Hôpital Privé du Confluent Nantes
France Hospices Civils de Lyon Hôpital Lyon Sud Pierre-benite
France Centre Armoricain de Radiothérapie, dImagerie Méd Plerin
France Centre Eugène Marquis Rennes Cedex
France Institut Claudius Regaud - IUCT-O Toulouse
France Institut Gustave Roussy Villejuif
Germany Helios Klinikum Berlin-Buch Berlin
Germany Gynakologisches Zentrum Bonn, Schwerpunkt Gyn. Onkologie, Bonn
Germany Universitätsklinikum Erlangen, Frauen klinik Erlangen
Germany Kliniken Essen-Mitte - Evangelische Huyssens-Stift Breast Unit Essen
Germany Praxis für interdisziplinäre Onkologie & Hämatolog Freiburg
Germany Facharztzentrum Eppendorf Hamburg
Germany Universitatsklinikum Hamburg-Eppendorf Hamburg
Germany Nationales Centrum für Tumorerkrankungen - Heidelb Heidelberg
Germany Klinik Frauenheilkunde, Uniklinik ClO, Studienzentrale Köln
Germany Universitätsklinikum Schleswig-Holstein Institut fur Klinische Chermie Lübeck
Germany Universitatsklinikum Mannheim GmBH, Frauenklinik Mannheim
Germany Evangelisches Krankenhaus Bethesda Mönchengladbach Mönchengladbach
Germany Klinik und Poliklinik für Frauenheilkunde München
Germany Rotkreuzklinikum Munchen München
Germany Universitätsklinikum Münster, Bereich Senologie an der klinik fur Frauenheilkunde und Gerburtschilfe Munster
Germany Universitätsklinikum Tübingen Tübingen
Germany St. Josefs-Hospital Wiesbaden GmbH , Gynäkologie und Geburtshilfe Wiesbaden
Hong Kong Hong Kong Integrated Oncology Centre Hong Kong
Hong Kong Queen Mary Hospital Hong Kong
Hong Kong Tuen Mun Hospital Hong Kong
Hong Kong Prince of Wales Hospital - Hong Kong New Territories
Hong Kong Queen Mary Hospital Pok Fu Lam
Hungary Uzsoki Utcai Kornaz, Onkoradiologiai Osztaly Budapest
Hungary Debreceni Egyetem Klinikai Központ Debrecen
Hungary Petz Aladar Egyetemi Oktaté Kérhaz - Osztaly Gyor
Israel Soroka Medical Center Beer-Sheva
Israel Rambam Health Care Campus Haifa
Israel Hadassah - Hebrew University Medical Center Jerusalem
Israel Shaare Zedek Medical Center Jerusalem
Israel Meir Medical Center Kfar Saba
Israel Rabin Medical Center Petah Tikva
Israel Kaplan Medical Center Rehovot
Israel Sheba Medical Center Hospital - Tel Hashomer Tel Aviv
Israel Tel Aviv Sourasky Medical Center Tel Aviv
Italy IRCCS Istituto Tumori "G.Paolo II" Bari
Italy SSD Oncologia Medica Addarii-Zamagni, IRCSS Azienda Ospedaliero-Universitaria di Bologna - Policlinico di Sant'Orsola Bologna
Italy UO Oncologia, ASST degli Spedali Civili di Brescia Brescia
Italy IRCSS Ospedale Policlinico San Martino Genova GE
Italy S.C. Oncologia medica, ASST di Lecco Lecco
Italy Presidio Ospedaliero di Lucca Lucca
Italy Ospedale Generale Provinciale - Macerata Macerata
Italy Istituto Europeo di Oncologia Milan
Italy Fondazione IRCCS - Istituto Nazionale dei Tumori Milano
Italy Azienda Socio Sanitaria Territoriale Monza
Italy Oncologia Medica Senologica Sperimentale - Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Napoli
Italy Azienda Ospedaliero-Universitaria Maggiore della C Novara
Italy Istituto Oncologico Veneto - IRCCS Padova
Italy S.O.C Patologia Clinica (Laboratorio Analisi), Nuovo Ospedale di Prato - Santo Stefano Prato
Italy AOU Policlinico Umberto I Roma
Italy Fondazione Policlinico Universitario Agostino Geme Rome
Italy Azienda Ospedaliera Universitaria Senese - Losped Siena
Japan Aichi Cancer Center Hospital Aichi
Japan Tohoku University Hospital Aoba-ku
Japan Juntendo University Hospital Bunkyo-ku
Japan Chiba Cancer Center Chuo-ku
Japan Osaka Prefectural Hospital Organization - Osaka In Chuo-ku
Japan Shikoku Cancer Center Ehime
Japan Fukushima Medical University Hospital Fukushima
Japan Saitama Cancer Center Inamachi
Japan Hakuaikai Sagara Hospital Kagoshima-shi
Japan Tokai University Hospital Kanagawa
Japan National Cancer Center Hospital East Kashiwa
Japan Cancer Institute Hospital of JFCR Koto-ku
Japan Kumamoto University Hospital Kumamoto- shi
Japan Kure Medical Center And Chugoku Cancer Center Kure
Japan Mie University Hospital Mie
Japan National Hospital Organization Kyushu Cancer Center Minami-ku
Japan Nagoya City University Hospital Nagoya
Japan Nagoya University Hospital Nagoya
Japan Hiroshima City Hiroshima Citizens Hospital Naka-ku
Japan Niigata Cancer Center Hospital Niigata-shi
Japan Okayama University Hospital Okayama
Japan Gunma Prefectural Cancer Center Ota
Japan Kyoto University Hospital Sakyo-ku
Japan Hokkaido Cancer Center Sapporo
Japan Shizuoka Cancer Center Shizuoka
Japan Shizuoka General Hospital Shizuoka-city
Japan Osaka University Hospital Suita
Japan Showa University Hospital Tokyo
Japan Kanagawa Cancer Center Yokohama
Korea, Republic of National Cancer Center Goyang-si Gyeonggi-do
Korea, Republic of Seoul National University Bundang Hospital Seongnam-si
Korea, Republic of Asan Medical Center Seoul
Korea, Republic of Korea University Anam Hospital Seoul
Korea, Republic of Samsung Medical Center Seoul
Korea, Republic of Seoul National University Hospital Seoul
Korea, Republic of Severance Hospital, Yonsei University Health System Seoul
Korea, Republic of The Catholic University of Korea, Seoul St. Mary's Hospital Seoul
Malaysia Hospital Pulau Pinang Georgetown
Malaysia Hospital Sultan Ismail Johor Bahru
Malaysia Hospital Kuala Lumpur Kuala Lumpur
Malaysia Pantai Hospital Kuala Lumpur Kuala Lumpur
Malaysia University Malaya Medical Centre (UMMC) Kuala Lumpur
Malaysia Institut Kanser Negara Putrajaya
Malaysia Hospital Wanita dan Kanak-Kanak Sabah Sabah
Malaysia Sarawak General Hospital Sarawak
Mexico Icaro Investigaciones en Medicina Chihuahua
Mexico Cryptex Investigación Clínica Ciudad de Mexico
Mexico Sinacor - Centro para el Desarrollo de la Medicina Culiacan
Mexico Panamerican Clinical Research Mexico - Guadalajara Guadalajara
Mexico Medical Care and Research S.A. de C.V. Merida
Mexico Fucam A.C. México
Mexico Avix Investigacion Clinica S.C. Monterrey
Mexico Oncológico Potosino San Luis Potosi
Mexico FAICIC Clínical Research Veracruz
Mexico iBiomed - Investigacion Biomedica para el Desarrol Zapopan
Netherlands Amphia Ziekenhuis - Breda Langendijk Breda
Netherlands Universitair Medisch Centrum Groningen Groningen
Netherlands Medisch Centrum Leeuwarden Leeuwarden
Netherlands Maastricht Universitair Medisch Centrum Maastricht
Netherlands Erasmus Medisch Centrum Rotterdam
Poland Uniwersyteckie Centrum Kliniczne, Klinika Onkologii i Radioterapii Gdansk
Poland Narodowy Instytut Onkologii im. Marii Sklodowskiej Gliwice
Poland SP ZOZ Opolskie Centrum Onkologii im. prof. Tadeusza Koszarowskiego Opole
Poland Wielkopolskie Centrum Onkologii im. Marii Sklodowskiej-Curie Poznan
Poland Mazowiecki Szpital Wojewódzki im. w. Jana Pawa II Siedlce
Poland Wojskowy Instytut Medyczny Warsaw
Poland Narodowy Instytut Onkologii im.Marii Marii Sklodowskiej Warszawa
Puerto Rico Ponce Medical School Foundation Inc. Ponce
Puerto Rico Clinical Research Puerto Rico San Juan
Romania Spitalul Clinic Filantropia Bucharest
Romania Institutal Oncologic, Prof. Dr Ion Chiricuta Cluj-Napoca
Romania SC Medisprof SRL Cluj-Napoca
Romania Centrul De Oncologie Sf Nectarie Craiova
Romania S.C. Oncomed S.R.L Timisoara
Singapore Curie Oncology Singapore
Singapore National University Hospital Singapore
Singapore Raffles Hospital Singapore
Slovakia Národný onkologický ústav Bratislava
Slovakia Onkologicky Ustav Sv. Alzbety Bratislava
Slovakia Vychodoslovensky onkologicky ustav, a.s., Oddelenie klinickej onkologie Košice
Slovakia Nemocnica Partizánske Partizánske
South Africa Hopelands Cancer Centre Hilton
South Africa The Medical Oncology Centre of Rosebank Johannesburg
South Africa Wits Clinical Research Johannesburg
South Africa University of Pretoria Pretoria
Spain Hospital Teresa Herrera - Materno Infantil A Coruña
Spain Hospital Clinic Barcelona Barcelona
Spain Hospital de la Santa Creu i Sant Pau Barcelona
Spain Hospital Universitari Dexeus Barcelona
Spain Hospital Universitari Vall d'Hebrón Barcelona
Spain Hospital Universitario de Basurto Bilbo
Spain Hospital Universitari Arnau de Vilanova Lleida
Spain Hospital General Universitario Gregorio Maranon Madrid
Spain Hospital Universitario Fundación Jiménez Díaz Madrid
Spain MD Anderson Cancer Center Madrid Madrid
Spain Hospital Universitario Virgen de la Victoria Malaga
Spain Hospital General Universitario Morales Meseguer Murcia
Spain Hospital Universitario Virgen Macarena Sevilla
Spain Hospital Unviersitario Virgen del Rocio Sevilla
Spain Hospital Universitario de Canarias Tenerife
Spain Hospital Clínico Universitario de Valencia Valencia
Switzerland Kantonsspital Baden Baden
Switzerland Kantonsspital Baselland - Standort Liestal Liestal
Switzerland Kantonsspital St.Gallen St. Gallen
Switzerland Kantonsspital Winterthur Winterthur
Switzerland Brust-Zentrum AG Zürich
Taiwan Changhua Christian Hospital Changhua
Taiwan Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation Hualien City
Taiwan E-DA Cancer Hospital Kaohsiung City
Taiwan Kaohsiung Kaohsiung City
Taiwan Taipei Medical University - Shuang Ho Hospital, Ministry of Health and Welfare New Taipei City
Taiwan Taichung Taichung
Taiwan Taichung Veterans General Hospital Taichung
Taiwan Chi Mei Hospital, Lioying Tainan City
Taiwan National Cheng Kung University Hospital Tainan City
Taiwan MacKay Medical Foundation The Presbyterian Church in Taiwan MacKay Memorial Hospital Taipei
Taiwan National Taiwan University Hospital Taipei
Taiwan Tri-Service General Hospital Taipei
Taiwan Chang Gung Memorial Hospital, Linkou Taoyuan City
Turkey Baskent Uni. Dr Turgut Noyan Uyg. ve Aras. Merkezi Adana
Turkey Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi Ankara
Turkey Ankara Il Saglik Mudurlugu SBU Gulhane Egitim Ve A Ankara
Turkey Hacettepe Üniversitesi Hastanesi Ankara
Turkey Memorial Ankara Hastanesi Ankara
Turkey Trakya Universitesi Tip Fakultesi Hastanesi Edirne
Turkey Istanbul Il Saglik Mudurlugu Goztepe Prof. Dr. Sul Istanbul
Turkey Medipol Mega Universite Hastanesi Istanbul
Turkey Ege Universitesi Hastanesi Izmir
Turkey Medicana International Izmir Hastanesi Izmir
Turkey Acibadem Maslak Hastanesi Sariyer
Turkey VKV Amerikan Hastanesi Sisli
United Kingdom Gloucestershire Hospitals NHS Foundation Trust Cheltenham
United Kingdom Cancer Research UK Beatson Institute Glasgow
United Kingdom Leeds Teaching Hospitals NHS Trust Leeds
United Kingdom Barts Health NHS Trust London
United Kingdom Guy's and Saint Thomas' NHS Foundation Trust London
United Kingdom Royal Free London NHS Foundation Trust London
United Kingdom University College London Hospitals NHS Foundation London
United States AdventHealth Medical Group Altamonte Springs Florida
United States Florida Cancer Specialists - North Region Research Office,750 Orienta Ave Altamonte Springs Florida
United States Alaska Oncology and Hematology Anchorage Alaska
United States University of Michigan Ann Arbor Michigan
United States The Center for Cancer & Blood Disorders - Magnolia,515 W. Mayfield Rd. Arlington Texas
United States Northside Hospital,125 King Avenue Athens Georgia
United States Northside Hospital Atlanta Georgia
United States Northside Hospital,5670 Peachtree Dunwoody Rd. Atlanta Georgia
United States Piedmont Cancer Institute - Atlanta Atlanta Georgia
United States Piedmont Cancer Institute - Atlanta,1267 Hwy 54W Atlanta Georgia
United States Rocky Mountain Cancer Centers,1700 South Potomac Street Aurora Colorado
United States Texas Oncology PA Austin Texas
United States Texas Oncology PA,4101 James Casey, Suite 100 Austin Texas
United States Texas Oncology PA,901 West 38th Street Austin Texas
United States New York Cancer & Blood Specialists - Port Jeffers,72 East Main St. Babylon New York
United States Cancer Institute Ascension Saint Agnes Baltimore Maryland
United States Mercy Medical Center Baltimore Maryland
United States Hematology Oncology Clinic - Baton Rouge Baton Rouge Louisiana
United States Summit Medical Group Eastside Clinic,1 Diamond Hill Road Berkeley Heights New Jersey
United States Northside Hospital,308 Deep South Farm Rd, Suite 200 Blairsville Georgia
United States Florida Cancer Specialists,9776 Bonita Beach Road Southeast Suite 201 A Bonita Springs Florida
United States Beth Israel Deaconess Medical Center Boston Massachusetts
United States Dana-Farber Cancer Institute Boston Massachusetts
United States Massachusetts General Hospital Boston Massachusetts
United States Rocky Mountain Cancer Centers Boulder Colorado
United States Florida Cancer Specialists,3630 Manatee Avenue West Bradenton Florida
United States Florida Cancer Specialists,5985 Silver Falls Run Bradenton Florida
United States Florida Cancer Specialists - North Region Research Office,403 S. Kings Ave. Brandon Florida
United States Montefiore Medical Center - Montefiore Medical Park Bronx New York
United States New York Cancer & Blood Specialists - Port Jeffers,12 East 86th St, Suite 4 Bronx New York
United States New York Cancer & Blood Specialists - Port Jeffers,2330 Eastchester Road, Suite 360 Bronx New York
United States University of California Los Angeles - Jonsson Comprehensive Cancer Center,201 S. Buena Vista Street, Suite 200 Burbank California
United States The Center for Cancer & Blood Disorders - Magnolia,11805 South Freeway Burleson Texas
United States Northside Hospital,228 Riverstone Dr. Canton Georgia
United States Florida Cancer Specialists,1030 Commerce Creek Blvd Cape Coral Florida
United States Northwest Georgia Oncology Northwest Georgia Oncology Centers, PCCenters, PC,157 Clinic Avenue Carrollton Georgia
United States Northwest Georgia Oncology Northwest Georgia Oncology Centers, PCCenters, PC,100 Market Place Blvd Cartersville Georgia
United States Novant Health Cancer Institute - Forsyth,125 Queens Road, Suite 650 Charlotte North Carolina
United States Virginia Oncology Associates,744 N. Battlefield Blvd Chesapeake Virginia
United States Orchard Healthcare Research Inc,2845 North Sheridan Road, 1st Floor Chicago Illinois
United States Robert H. Lurie Comprehensive Cancer Center of Northwestern University Chicago Illinois
United States Rush University Medical Center Chicago Illinois
United States University of Illinois Hospital and Health Sciences System (Outpatient Cancer Center) Chicago Illinois
United States Florida Cancer Specialists - North Region Research Office,3280 McMullen Booth Road Clearwater Florida
United States Rocky Mountain Cancer Centers,2312 N. Nevada Avenue Colorado Springs Colorado
United States Rocky Mountain Cancer Centers,6031 E. Woodman Rd. Colorado Springs Colorado
United States Zangmeister Cancer Center Columbus Ohio
United States Northside Hospital,1505 Northside Blvd, Suite 4600 Cumming Georgia
United States Texas Oncology-Baylor Charles A. Sammons Cancer Center Dallas Texas
United States Massachusetts General Hospital,102 Endicott Street Danvers Massachusetts
United States Florida Cancer Specialists - West Palm Beach,224 Memorial Medical Parkway, Suite 300 Daytona Beach Florida
United States Robert H. Lurie Comprehensive Cancer Center of Northwestern University,1 Kish Hospital Drive DeKalb Illinois
United States Robert H. Lurie Comprehensive Cancer Center of Northwestern University,10 Health Services Drive DeKalb Illinois
United States Texas Oncology-Denison Denison Texas
United States Rocky Mountain Cancer Centers,4700 E. Hale Parkway Denver Colorado
United States Tennessee Oncology, PLLC,103 Natchez Park Drive Dickson Tennessee
United States Northside Hospital,3855 Pleasant Hill Rd., Suite 480 Duluth Georgia
United States Hematology Oncology Associates of Central New York East Syracuse New York
United States Swedish Cancer Institute-First Hill,21632 Highway 99 Edmonds Washington
United States Magee-Womens Hospital of UPMC,201 State Street, 6 Main Erie Pennsylvania
United States Magee-Womens Hospital of UPMC,2500 West 12th Street Erie Pennsylvania
United States Orchard Healthcare Research Inc,800 Austin Street, Suite 360, East Tower Evanston Illinois
United States Summit Medical Group Eastside Clinic Florham Park New Jersey
United States Holy Cross Hospital, Inc Fort Lauderdale Florida
United States Florida Cancer Specialists Fort Myers Florida
United States Florida Cancer Specialists,8260 Gladiolus Dr Fort Myers Florida
United States Florida Cancer Specialists,8981 Colonial Center Drive Fort Myers Florida
United States Fort Wayne Medical Oncology and Hematology - Fort Fort Wayne Indiana
United States The Center for Cancer & Blood Disorders - Magnolia Fort Worth Texas
United States Tennessee Oncology, PLLC,4488 Carothers Parkway Franklin Tennessee
United States Florida Cancer Specialists - North Region Research Office,6420 W. Newberry Road Gainesville Florida
United States Tennessee Oncology, PLLC,225 Big Station Camp Blvd Gallatin Tennessee
United States Robert H. Lurie Comprehensive Cancer Center of Northwestern University,300 Randall Road Geneva Illinois
United States Robert H. Lurie Comprehensive Cancer Center of Northwestern University,304 Randall Road Geneva Illinois
United States The West Clinic, PLLC dba West Cancer Center Germantown Tennessee
United States Nebraska Cancer Specialists,2730 W. Faidley Ave Grand Island Nebraska
United States Ascension St. John Hospital Grosse Pointe Woods Michigan
United States Magee-Womens Hospital of UPMC,4300 Londonberry Road Harrisburg Pennsylvania
United States Tennessee Oncology, PLLC,353 New Shackle Island Road Hendersonville Tennessee
United States Tennessee Oncology, PLLC,5653 First Blvd. Hermitage Tennessee
United States Genesis Cancer and Blood Institute Hot Springs Arkansas
United States Genesis Cancer and Blood Institute,1455 Higdon Ferry Road Suite B. Hot Springs Arkansas
United States Oncology Consultants Houston Texas
United States Oncology Consultants,1631 North Loop West Houston Texas
United States Oncology Consultants,925 Gessner Houston Texas
United States University of Iowa Hospitals and Clinics Iowa City Iowa
United States Swedish Cancer Institute-First Hill,751 NE Blakely Drive Issaquah Washington
United States Queens Hospital Center Jamaica New York
United States Rutgers Cancer Institute of New Jersey,414 Grand Street Jersey City New Jersey
United States Saint Bernards Medical Center Jonesboro Arkansas
United States The University of Kansas Cancer Center,2000 Olathe Blvd Kansas City Kansas
United States The University of Kansas Cancer Center,2750 Clay Edwards Drive Kansas City Missouri
United States The University of Kansas Cancer Center,8700 North Green Hills Road Kansas City Missouri
United States University of California San Diego Moores Cancer La Jolla California
United States University of California Los Angeles - Jonsson Comprehensive Cancer Center,24302 Paseo de Valencia, Suite 200 Laguna Hills California
United States Robert H. Lurie Comprehensive Cancer Center of Northwestern University,1000 N. Westmoreland Road Lake Forest Illinois
United States Rocky Mountain Cancer Centers,11750 West 2nd Place Lakewood Colorado
United States Rutgers Cancer Institute of New Jersey,600 River Avenue Lakewood New Jersey
United States Florida Cancer Specialists - North Region Research Office,100 Highland Avenue Largo Florida
United States Tennessee Oncology, PLLC,103 Physicians Way Lebanon Tennessee
United States Florida Cancer Specialists - North Region Research Office,521 North Lecanto Highway Lecanto Florida
United States The University of Kansas Cancer Center,4881 N.E. Goodview Circle Lee's Summit Missouri
United States Rocky Mountain Cancer Centers,22 West Dry Creek Circle Littleton Colorado
United States Rutgers Cancer Institute of New Jersey,94 Old Short Hills Road Livingston New Jersey
United States Rocky Mountain Cancer Centers,10107 Ridge Gate Parkway Lone Tree Colorado
United States Rutgers Cancer Institute of New Jersey,300 Second Ave Long Branch New Jersey
United States Rocky Mountain Cancer Centers,2030 Mountain View Ave Ste 210 Longmont Colorado
United States Cancer and Blood Specialty Clinic Los Alamitos California
United States Norton Cancer Institute - Saint Matthews Louisville Kentucky
United States Norton Cancer Institute - Saint Matthews,234 E. Gray Strret Louisville Kentucky
United States Norton Cancer Institute - Saint Matthews,4955 Norton Healthcare Blvd Louisville Kentucky
United States Norton Cancer Institute - Saint Matthews,676 S. Floyd Street Louisville Kentucky
United States Northside Hospital,308 Coliseum Dr. Macon Georgia
United States Northwest Georgia Oncology Northwest Georgia Oncology Centers, PCCenters, PC Marietta Georgia
United States Magee-Womens Hospital of UPMC,2035 Technology Parkway Mechanicsburg Pennsylvania
United States Virginia Cancer Specialists, PC,7501 Right Flank Road Mechanicsville Virginia
United States Tennessee Oncology, PLLC,1840 Medical Center Parkway Murfreesboro Tennessee
United States Florida Cancer Specialists,1100 Goodlette Road Naples Florida
United States Florida Cancer Specialists,681 4th Avenue North Naples Florida
United States Tennessee Oncology, PLLC Nashville Tennessee
United States Tennessee Oncology, PLLC,2004 Hayes Street Nashville Tennessee
United States Tennessee Oncology, PLLC,3443 Dickerson Road Nashville Tennessee
United States Tennessee Oncology, PLLC,397 Wallace Road Nashville Tennessee
United States Tennessee Oncology, PLLC,4220 Harding Rd Nashville Tennessee
United States Tennessee Oncology, PLLC,SCRI Oncology Partners Nashville Tennessee
United States Rutgers Cancer Institute of New Jersey New Brunswick New Jersey
United States New York Cancer & Blood Specialists - Port Jeffers,1 Delaware Dr. New Hyde Park New York
United States NYP/Columbia Univeresity Medical Center/Herbert Irving Comprehensive Cancer Center New York New York
United States Rutgers Cancer Institute of New Jersey,150 Bergen St. Newark New Jersey
United States Rutgers Cancer Institute of New Jersey,201 Lyons Avenue Newark New Jersey
United States Piedmont Cancer Institute - Atlanta,775 Poplar Road Newnan Georgia
United States Virginia Oncology Associates,1051 Loftis Blvd Suite 100 Newport News Virginia
United States Massachusetts General Hospital,2014 Washington St Newton Massachusetts
United States Virginia Oncology Associates Norfolk Virginia
United States Eastern Connecticut Hematology and Oncology Associates Norwich Connecticut
United States Rush University Medical Center,520 South Maple Ave Oak Park Illinois
United States Florida Cancer Specialists - North Region Research Office,4945 SW 49th Place Ocala Florida
United States Nebraska Cancer Specialists Omaha Nebraska
United States Nebraska Cancer Specialists,8303 Dodge Street Omaha Nebraska
United States Florida Cancer Specialists - North Region Research Office,2824 Enterprise Rd Orange City Florida
United States AdventHealth Medical Group,2501 North Orange Ave Orlando Florida
United States Florida Cancer Specialists - North Region Research Office,70 W. Gore Street Orlando Florida
United States The University of Kansas Cancer Center,10710 Nall Avenue Overland Park Kansas
United States The University of Kansas Cancer Center,10730 Nall Avenue Overland Park Kansas
United States The University of Kansas Cancer Center,12200 W. 110th Street Overland Park Kansas
United States Nebraska Cancer Specialists,611 Fenwick Dr Papillion Nebraska
United States Saint Bernards Medical Center,4000 Linwood Drive Paragould Arkansas
United States New York Cancer & Blood Specialists - Port Jeffers,365 East Main St. Patchogue New York
United States Capital Health Medical Center - Hopewell Pennington New Jersey
United States Sacred Heart Heatlh System, Inc., d/b/a Ascension Sacred Heart Pensacola Florida
United States Virginia Cancer Specialists, PC,210 Medical Park Boulevard Petersburg Virginia
United States University of Pennsylvania Abramson Cancer Center Philadelphia Pennsylvania
United States Magee-Womens Hospital of UPMC Pittsburgh Pennsylvania
United States Magee-Womens Hospital of UPMC,5115 Centre Avenue Pittsburgh Pennsylvania
United States Florida Cancer Specialists,22395 Edgewater Drive Port Charlotte Florida
United States New York Cancer & Blood Specialists - Port Jeffers,1500 Rte, 112, Building 4 Port Jefferson New York
United States New York Cancer & Blood Specialists - Port Jeffers Port Jefferson Station New York
United States New York Cancer & Blood Specialists - Port Jeffers,49 Rte. 347, Newconset Hwy Port Jefferson Station New York
United States Northwest Cancer Specialists, P.C,265 N. Broadway Portland Oregon
United States Northwest Cancer Specialists, P.C,5050 NE Hoyt St. Portland Oregon
United States Rocky Mountain Cancer Centers,3676 Parker Blvd Pueblo Colorado
United States Rocky Mountain Cancer Centers,525 W. 15th Street Pueblo Colorado
United States Virginia Cancer Specialists, PC Richmond Virginia
United States Virginia Cancer Specialists, PC,1401 Johnston-Willis Drive Richmond Virginia
United States New York Cancer & Blood Specialists - Port Jeffers,750 Old County Rd. Suite 4 Riverhead New York
United States Florida Cancer Specialists - North Region Research Office Saint Petersburg Florida
United States Florida Cancer Specialists - North Region Research Office,1201 Fifth Avenue North Saint Petersburg Florida
United States Mays Cancer Center San Antonio Texas
United States University of California Los Angeles - Jonsson Comprehensive Cancer Center,892 Aerovista Place, Suite 240 San Luis Obispo California
United States Sansum Clinic Santa Barbara California
United States University of California Los Angeles - Jonsson Comprehensive Cancer Center Santa Monica California
United States University of California Los Angeles - Jonsson Comprehensive Cancer Center,2020 Santa Monica Blvd, Suite 600 Santa Monica California
United States University of California Los Angeles - Jonsson Comprehensive Cancer Center,2336 Santa Monica, Suites 302 and 304 Santa Monica California
United States Sacred Heart Heatlh System, Inc., d/b/a Ascension Sacred Heart,27 Mack Bayou Loop Santa Rosa Beach Florida
United States Florida Cancer Specialists,1970 Golf Street Sarasota Florida
United States Florida Cancer Specialists,600 North Cattlemen Road Sarasota Florida
United States Swedish Cancer Institute-First Hill Seattle Washington
United States Swedish Cancer Institute-First Hill,747 Broadway Seattle Washington
United States Tennessee Oncology, PLLC,120 Frank Martin Road Shelbyville Tennessee
United States Orchard Healthcare Research Inc Skokie Illinois
United States Tennessee Oncology, PLLC,300 Stonecrest Blvd Smyrna Tennessee
United States Sansum Clinic,2040 Viborg Road Solvang California
United States Rutgers Cancer Institute of New Jersey,110 Rehill Ave Somerville New Jersey
United States The West Clinic, PLLC dba West Cancer Center,7668 Airways Blvd Southaven Mississippi
United States Ascension Providence Hospital Southfield Michigan
United States Florida Cancer Specialists - North Region Research Office,7154 Medical Center Drive Spring Hill Florida
United States Piedmont Cancer Institute - Atlanta,1240 Eagles Landing Pkwy Stockbridge Georgia
United States Florida Cancer Specialists - West Palm Beach,301 SE Ocean Blvd, Suite 102 Stuart Florida
United States Florida Cancer Specialists - North Region Research Office,3402 West Dr. Martin Luther King Jr. Boulevard Tampa Florida
United States Florida Cancer Specialists - North Region Research Office,4100 Waterman Way Tavares Florida
United States Florida Cancer Specialists - North Region Research Office,1400 US Highway 441 N The Villages Florida
United States Rocky Mountain Cancer Centers,8820 Huron Street Thornton Colorado
United States Northwest Cancer Specialists, P.C Tigard Oregon
United States Rutgers Cancer Institute of New Jersey,99 Highway 37 West Toms River New Jersey
United States Torrance Memorial Physician Network - Cancer Care Torrance California
United States Florida Cancer Specialists - North Region Research Office,9320 State Road 54 Trinity Florida
United States Arizona Oncology Associates, PC-Hope Tucson Arizona
United States Arizona Oncology Associates, PC-Hope,1620 West St. Mary's Road Tucson Arizona
United States Arizona Oncology Associates, PC-Hope,1845 W Orange Grove Rd Tucson Arizona
United States Arizona Oncology Associates, PC-Hope,2070 W. Rudasill Rd. Tucson Arizona
United States Northwest Cancer Specialists, P.C,210 SE 136th Avenue Vancouver Washington
United States Florida Cancer Specialists,836 Sunset Lake Blvd Venice Florida
United States Florida Cancer Specialists,901 South Tamiami Trail Venice Florida
United States Florida Cancer Specialists - West Palm Beach,3730 7th Terrace, Suite 101 Vero Beach Florida
United States Virginia Oncology Associates,1950 Glenn Mitchell Drive Virginia Beach Virginia
United States Robert H. Lurie Comprehensive Cancer Center of Northwestern University,4405 Weaver Parkway Warrenville Illinois
United States Robert H. Lurie Comprehensive Cancer Center of Northwestern University,4455 Weaver Parkway Warrenville Illinois
United States The Center for Cancer & Blood Disorders - Magnolia,920 Santa Fe Drive Weatherford Texas
United States Florida Cancer Specialists - West Palm Beach,1037 S. State Road 7, Bldg B, Suite 303 Wellington Florida
United States Rutgers Cancer Institute of New Jersey,100 State Route 36 West Long Branch New Jersey
United States Florida Cancer Specialists - West Palm Beach West Palm Beach Florida
United States University of California Los Angeles - Jonsson Comprehensive Cancer Center,1250 La Venta Dr, Suite 100 Westlake Village California
United States The University of Kansas Cancer Center Westwood Kansas
United States Novant Health Cancer Institute - Forsyth,2131 S. 17th Street Wilmington North Carolina
United States Robert H. Lurie Comprehensive Cancer Center of Northwestern University,25 N Winfield Road Winfield Illinois
United States Novant Health Cancer Institute - Forsyth Winston-Salem North Carolina
United States Florida Cancer Specialists - North Region Research Office,460 N Orlando Ave Winter Park Florida
United States Magee-Womens Hospital of UPMC,1703 Innovation Drive York Pennsylvania
United States Hematology Oncology Clinic - Baton Rouge,1673 E Mount Please Drive Zachary Louisiana

Sponsors (1)

Lead Sponsor Collaborator
Gilead Sciences

Countries where clinical trial is conducted

United States,  Argentina,  Australia,  Austria,  Belgium,  Brazil,  Canada,  Chile,  China,  Czechia,  France,  Germany,  Hong Kong,  Hungary,  Israel,  Italy,  Japan,  Korea, Republic of,  Malaysia,  Mexico,  Netherlands,  Poland,  Puerto Rico,  Romania,  Singapore,  Slovakia,  South Africa,  Spain,  Switzerland,  Taiwan,  Turkey,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Progression-free Survival (PFS) as Assessed by Blinded Independent Central Review (BICR) per Response Evaluation Criteria in Solid Tumors (RECIST) Version 1.1 PFS is defined as the time from the date of randomization until the date of objective progressive disease (PD), or death (whichever comes first). Randomization up to approximately 22 months
Secondary Overall Survival (OS) OS is defined as the time from the date of randomization until death due to any cause. Randomization up to approximately 57 months
Secondary Objective Response Rate (ORR) as Assessed by BICR per RECIST Version 1.1 ORR is defined as the proportion of participants who achieve a complete response (CR) or partial response (PR) that is confirmed at least 4 weeks after initial documentation of response. Randomization up to approximately 57 months
Secondary Duration of Response (DOR) as Assessed by BICR per RECIST Version 1.1 DOR is defined as the time from the first documentation of CR or PR to the earlier of the first documentation of definitive PD or death from any cause (whichever comes first). Randomization up to approximately 57 months
Secondary Time to Response (TTR) as Assessed by BICR per RECIST Version 1.1 TTR is defined as the time from the date of randomization until the first documentation of CR or PR. Randomization up to approximately 57 months
Secondary Percentage of Participants Experiencing Treatment-emergent Adverse Events (TEAEs) First dose date up to approximately 57 months plus 30 days
Secondary Percentage of Participants Experiencing Clinical Laboratory Abnormalities First dose date up to approximately 57 months plus 30 days
Secondary Change from Baseline in the Physical Functioning Domain as Measured by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire, Core Questionnaire, Version 3.0 (EORTC QLQ-C30). The EORTC QLQ-C30 is a questionnaire to assess quality of life of cancer patients, it is composed of 30 questions (items) to assess 15 scales; 1 global health status/quality of life (QOL), 5 functional scales (physical, role, cognitive, emotional, and social), and 9 symptom/item scales(fatigue, nausea and vomiting, pain, dyspnea, insomnia, appetite loss, constipation, diarrhea, and financial difficulties). All of the scales and single-item measures range in score from 0 to 100. A high scale score represents a higher response level. Thus, a high score for a functional scale represents a high/healthy level of function, a high score for the global health status/QOL represents a high QOL, but a high score for a symptom scale/item represents a high level of symptomatology/problems. Randomization up to approximately 57 months
Secondary Time to Deterioration (TTD) of Fatigue Scale of the EORTC QLQ-C30 TTD is defined as the time between the date of randomization and the date of assessment at which a patient experienced a deterioration (= 10 points deterioration from baseline in the fatigue scale) or death. Randomization up to approximately 57 months
See also
  Status Clinical Trial Phase
Recruiting NCT05174832 - Induction of Cisplatin/Nab-paclitaxel/Pembrolizumab Followed by Olaparib/Pembrolizumab Maintenance in mTNBC Patients Phase 2
Active, not recruiting NCT03667716 - COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. Phase 1
Withdrawn NCT03634150 - Safety and Efficacy of IV Nerofe™ Followed by Doxorubicin, In Metastatic Ovarian Cancer and Triple Negative Breast Cancer Phase 1/Phase 2
Recruiting NCT03348098 - Clinical Study of Neoadjuvant Therapy With Apatinib and Paclitaxel in Local Advanced Triple-negative Breast Cancer Phase 2
Completed NCT04032080 - LY3023414 and Prexasertib in Metastatic Triple-negative Breast Cancer Phase 2
Active, not recruiting NCT03170960 - Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors Phase 1/Phase 2
Withdrawn NCT02427581 - Safety and Immunogenicity of a Personalized Synthetic Long Peptide Breast Cancer Vaccine Strategy in Patients With Persistent Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy Phase 1
Recruiting NCT03165487 - Comparison of the Breast Tumor Microenvironment
Completed NCT02225470 - Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes Phase 3
Recruiting NCT04452370 - Oral Etoposide Combined With Anlotinib in Advanced Triple Negative Breast Cancer Phase 2
Terminated NCT04123704 - Sitravatinib in Metastatic Breast Cancer Phase 2
Recruiting NCT04758780 - Imaging Performance Assessment of 89Zirconium-labelled Girentuximab (89Zr-TLX250) PET-CT in Metastatic Triple Negative Breast Cancer Patients Phase 2
Withdrawn NCT04268693 - Bisphenol and Phthalate Exposures in Triple Negative Breast Cancer
Withdrawn NCT03982173 - Basket Trial for Combination Therapy With Durvalumab (Anti-PDL1) (MEDI4736) and Tremelimumab (Anti-CTLA4) in Patients With Metastatic Solid Tumors Phase 2
Not yet recruiting NCT02685657 - Neoadjuvant Chemotherapy Docetaxel With or Without SELUMETINIB in Patients With Triple Negative Breast Cancer Phase 2
Terminated NCT01918306 - GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast Cancer Phase 1/Phase 2
Completed NCT01276899 - Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients
Completed NCT00998036 - Study of Temsirolimus, Erlotinib and Cisplatin in Solid Tumors Phase 1
Recruiting NCT05309655 - Cardiac Outcomes With Near-Complete Estrogen Deprivation Early Phase 1
Active, not recruiting NCT03267316 - A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors Phase 1/Phase 2

External Links